Skip to content

ARDX

ARDELYX, INC.

NASDAQ · Healthcare · Biotechnology · US

$3.29
+8.58%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue468.2M407.3M333.6M124.5M52.2M
Cost of Revenue26.9M42.6M50.6M17.8M4.1M
Gross Profit441.3M364.7M283.1M106.7M48.0M
Operating Expenses
R&D Expense93.4M68.5M52.3M35.5M35.2M
SG&A Expense384.0M337.2M258.7M134.4M76.6M
General & Admin Expense————76.6M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses477.4M405.7M311.0M169.9M111.8M
Cost and Expenses504.3M448.3M361.6M187.7M115.9M
Operating Income (EBIT)(36.1M)(41.0M)(27.9M)(63.3M)(63.8M)
Non-Operating
Interest Income—————
Interest Expense13.6M28.4M20.1M8.9M5.1M
Net Interest Income(19.4M)(28.4M)(20.1M)(8.9M)(5.1M)
Other Non-Op Income/Expense(19.2M)(19.7M)(10.9M)(2.2M)(3.4M)
Non-Operating Income (excl Interest)(5.0M)(8.7M)(9.2M)(6.6M)(1.6M)
EBT (Pre-Tax Income)(55.3M)(60.6M)(38.9M)(65.5M)(67.2M)
Income Tax Expense215.0K969.0K266.0K547.0K8.0K
Bottom Line
Net Income(55.5M)(61.6M)(39.1M)(66.1M)(67.2M)
Earnings from Cont. Ops(55.5M)(61.6M)(39.1M)(66.1M)(67.2M)
Earnings from Discont. Ops—————
Bottom Line Net Income(55.5M)(61.6M)(39.1M)(66.1M)(67.2M)
Per Share
Basic EPS($0.22)($0.26)($0.17)($0.30)($0.42)
Diluted EPS($0.22)($0.26)($0.17)($0.30)($0.42)
Revenue Per Share$1.87$1.69$1.42$0.57$0.33
Shares
Basic Shares Outstanding250.0M241.0M235.2M219.3M158.7M
Diluted Shares Outstanding250.0M241.0M235.2M219.3M158.7M
Profitability Metrics
EBITDA(28.7M)(29.2M)(16.7M)(55.4M)(61.0M)
D&A2.4M3.1M2.1M1.3M1.1M
EBIT(35.2M)(32.2M)(18.8M)(56.6M)(62.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026